Phase 1 CARDINAL trial evaluating TERN-701 in 2L+ CML patients remains ongoing, with interim data from initial cohorts anticipated in second half of 2024 FOSTER CITY, Calif., April 29, 2024 (GLOBE ...
Blocking the NAD hydrolase may save axons from neurodegeneration, if researchers can figure out a safe way to do it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results